NCT04155411 2022-07-27
Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP
Shenzhen Second People's Hospital
Phase 4 Unknown
Clinical Trials
40 trialsNCT05353205 2022-04-29
A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 4 Unknown
NCT05340985 2022-04-22
Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis
Tehran University of Medical Sciences
Phase 4 Unknown
NCT02602314 2022-01-20
SUSTRENIM
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 4 Unknown
NCT01358201 2022-01-19
PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years
PETHEMA Foundation
Phase 4 Unknown
NCT01366898 2022-01-19
Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)
PETHEMA Foundation
Phase 4 Unknown
NCT05137860 2022-01-18
Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD
Hospital General de Mexico
Phase 4 Unknown
NCT05133310 2022-01-04
Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia
Hospital General de Mexico
Phase 4 Unknown
NCT04636918 2020-11-19
Ikervis
Singapore Eye Research Institute
Phase 4 Unknown
NCT03908138 2019-11-29
RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma
Shandong Provincial Hospital
Phase 4 Unknown
NCT01987297 2019-08-19
Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL
Shanghai Jiao Tong University School of Medicine
Phase 4 Unknown
NCT03920813 2019-04-23
Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance Therapy
Shandong University
Phase 4 Unknown
NCT02933333 2018-10-17
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4 Unknown
NCT03558412 2018-09-14
A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic Lymphoma
Zhengzhou University
Phase 4 Unknown
NCT01906671 2018-04-20
Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral Liquid
Rigshospitalet, Denmark
Phase 4 Unknown
NCT03216070 2017-07-13
Low-dose Dasatinib as First-line Treatment for Chronic Myeloid Leukemia
Hospital Universitario Dr. Jose E. Gonzalez
Phase 4 Unknown
NCT03150134 2017-05-12
Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4 Unknown
NCT03026842 2017-01-20
Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)
The First Hospital of Jilin University
Phase 4 Unknown
NCT02576327 2016-12-30
A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation
Peking University
Phase 4 Unknown
NCT02938741 2016-10-25
ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4 Unknown
NCT02894645 2016-09-30
Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study
National University Hospital, Singapore
Phase 4 Unknown
NCT02027064 2016-09-29
Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT
Peking University People's Hospital
Phase 4 Unknown
NCT02784561 2016-05-27
Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation
Chinese PLA General Hospital
Phase 4 Unknown
NCT02389920 2015-03-17
Multicenter, Phaseâ…£, Open Label Trial of Nilotinib in Adult Patients Diagnosed Philadelphia Chromosome Positive(Ph+) Chronic Myeloid Leukemia in CP/AP Intolerant to Dasatinib
Samsung Medical Center
Phase 4 Unknown
NCT02347878 2015-01-27
Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH)
Sun Yat-sen University
Phase 4 Unknown
NCT02317159 2014-12-15
Efficacy and Safety of Imatinib Mesylate as First-line Treatment for the Patients With Chronic Phase of Chronic Myeloid Leukemia
Cttq
Phase 4 Unknown
NCT02277847 2014-10-29
Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia
Guangdong Provincial People's Hospital
Phase 4 Unknown
NCT01587430 2014-04-07
3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia
National Research Center for Hematology, Russia
Phase 4 Unknown
NCT02024308 2013-12-31
AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy
Changhai Hospital
Phase 4 Unknown
NCT01901666 2013-07-17
Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission
PIMERIndia
Phase 4 Unknown
NCT01806116 2013-03-12
DFMBHSCT
The First Affiliated Hospital of Soochow University
Phase 4 Unknown
NCT00180128 2011-07-11
AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia
Technische Universität Dresden
Phase 4 Unknown
NCT01339988 2011-04-21
Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)
Tel-Aviv Sourasky Medical Center
Phase 4 Unknown
NCT00846703 2010-03-08
The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia
Sun Yat-sen University
Phase 4 Unknown
NCT00222612 2010-02-03
Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003
University of Oxford
Phase 4 Unknown
NCT00192673 2009-09-30
Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses
Nordic Society for Pediatric Hematology and Oncology
Phase 4 Unknown
NCT00797810 2009-09-15
Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults
University of Bologna
Phase 4 Unknown
NCT00838019 2009-02-06
Intrabone Cord Blood Transplantation
Hospital Clinic of Barcelona
Phase 4 Unknown
NCT00196768 2007-10-23
Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic
German AML Cooperative Group
Phase 4 Unknown
NCT00131313 2005-08-18
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
East Valley Hematology and Oncology Medical Group
Phase 4 Unknown